Skip to content
10-K/A

Annual Report

Silexion Therapeutics Corp SLXN SLXNW

0001178913-26-002805

← back to feed
Filed
May 19, 2026 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding restated FY 2025 · Mar 10, 2026 3.33M sh